Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients
NCT03844555
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Renal Insufficiency
Kidney Diseases
Pharmacokinetics
Interventions
DRUG:
Elafibranor
Sponsor
Genfit